These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25206523)

  • 1. Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke.
    Min L; Shao S; Wu X; Cong L; Liu P; Zhao H; Luo Y
    Neural Regen Res; 2013 Aug; 8(23):2144-54. PubMed ID: 25206523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin treatment and carotid plaque morphology in first-ever atherosclerotic transient ischemic attack/stroke: a case-control study.
    Marchione P; Vento C; Morreale M; Izzo C; Maugeri A; Manuppella F; Romeo T; Giacomini P
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):138-43. PubMed ID: 25440329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies on the effects of different doses of atorvastatin combined with aspirin on inflammatory cytokines and carotid plaques in patients with ischemic cerebrovascular disease.
    Deng Y; Zou W; Chen G; Shangguan S; Zhou F; Jiang W; Li X
    Int J Neurosci; 2019 Nov; 129(11):1133-1138. PubMed ID: 31232139
    [No Abstract]   [Full Text] [Related]  

  • 4. Early High-dosage Atorvastatin Treatment Improved Serum Immune-inflammatory Markers and Functional Outcome in Acute Ischemic Strokes Classified as Large Artery Atherosclerotic Stroke: A Randomized Trial.
    Tuttolomondo A; Di Raimondo D; Pecoraro R; Maida C; Arnao V; Della Corte V; Simonetta I; Corpora F; Di Bona D; Maugeri R; Iacopino DG; Pinto A
    Medicine (Baltimore); 2016 Mar; 95(13):e3186. PubMed ID: 27043681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.
    Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Liapis CD
    J Vasc Surg; 2010 Jan; 51(1):114-21. PubMed ID: 19837545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study.
    Macin SM; Perna ER; Farías EF; Franciosi V; Cialzeta JR; Brizuela M; Medina F; Tajer C; Doval H; Badaracco R
    Am Heart J; 2005 Mar; 149(3):451-7. PubMed ID: 15864233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
    JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Sillesen H; Amarenco P; Hennerici MG; Callahan A; Goldstein LB; Zivin J; Messig M; Welch KM;
    Stroke; 2008 Dec; 39(12):3297-302. PubMed ID: 18845807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin Reduces Plasma Inflammatory and Oxidant Biomarkers in Patients With Risk of Atherosclerotic Cardiovascular Disease.
    Mayyas F; Baydoun D; Ibdah R; Ibrahim K
    J Cardiovasc Pharmacol Ther; 2018 May; 23(3):216-225. PubMed ID: 29343081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intervention Effects of Atorvastatin Combined with
    Jiang QF; Huang MY; Wu KY; Weng JL; Deng RG; Xu XJ; Xu JP; Jiang T
    Pharmacogn Mag; 2017; 13(51):430-438. PubMed ID: 28839368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
    Joukhadar C; Klein N; Prinz M; Schrolnberger C; Vukovich T; Wolzt M; Schmetterer L; Dorner GT
    Thromb Haemost; 2001 Jan; 85(1):47-51. PubMed ID: 11204586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of atorvastatin and/or probucol on recovery of atherosclerosis in high-fat-diet-fed apolipoprotein E-deficient mice.
    Guo X; Wang L; Xia X; Wang P; Li X
    Biomed Pharmacother; 2019 Jan; 109():1445-1453. PubMed ID: 30551396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial.
    Shukla A; Sharma MK; Jain A; Goel PK
    Indian Heart J; 2005; 57(6):675-80. PubMed ID: 16521637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The statin dosage for achieving goal of cholesterol-lowering based on risk stratification in patients with ischemic cerebrovascular diseases].
    Tan ZF; Guo YD; Xu AD; Yang WY; Fu YG; Wang TG
    Zhonghua Nei Ke Za Zhi; 2009 Apr; 48(4):280-3. PubMed ID: 19576114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in flow-mediated dilatation, cytokines and carotid arterial stenosis during aggressive atorvastatin treatment in normocholesterolemic patients.
    Hsu HY; Wang PY; Chen YT; Sheu WH; Hu HH; Sheng WY
    J Chin Med Assoc; 2005 Feb; 68(2):53-8. PubMed ID: 15759815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.
    Schwartz GG; Olsson AG; Ezekowitz MD; Ganz P; Oliver MF; Waters D; Zeiher A; Chaitman BR; Leslie S; Stern T;
    JAMA; 2001 Apr; 285(13):1711-8. PubMed ID: 11277825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atorvastatin on lipogenic, inflammatory and thrombogenic markers in women with the metabolic syndrome.
    Velarde GP; Choudhary N; Bravo-Jaimes K; Smotherman C; Sherazi S; Kraemer DF
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):634-640. PubMed ID: 33485731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium ozagrel and atorvastatin for type 2 diabetes patients with lacunar cerebral infarction.
    Yu Y; Wang L; Zhu X; Liu YF; Ma HY
    World J Diabetes; 2021 Dec; 12(12):2096-2106. PubMed ID: 35047123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin as adjunctive therapy for chronic plaque type psoriasis versus betamethasone valerate alone: A randomized, double-blind, placebo-controlled trial.
    Chua SHH; Tioleco GMS; Dayrit CAF; Mojica WP; Dofitas BL; Frez LF
    Indian J Dermatol Venereol Leprol; 2017; 83(4):441-447. PubMed ID: 28540870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.